Does Alex Heisenberg(Hedges) wants to cover before FDA decision on Friday..!!
One way he compare Vascepa with OTC products and then he says bull side of the coin, Vascepa may not have much commercial value for the current indication, but there's two other far more meaningful and far more potentially commercially successful trials in Phase III which could be game changers, called the ANCHOR trial and the REDUCE-IT trial.
DOES IT MEAN THAT .....VASCEPA CHANGED THE CONTENT FOR DIFFERENT INDICATION !!
VERY FUNNY ......
He is trying to say that You SELL now otherwise ( His paid Hedge Fund is in deep Shiiiiiitttt before Friday when FDA approves the NCE status )